131 related articles for article (PubMed ID: 37088259)
1. A qualitative analysis of patient's lived experience on their treatment journey with nasopharyngeal carcinoma.
Ng JPZ; Lam WYH; Pow EHN; Botelho MG
J Dent; 2023 Jul; 134():104518. PubMed ID: 37088259
[TBL] [Abstract][Full Text] [Related]
2. Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study.
Wang R; Wu F; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
J Cancer Res Clin Oncol; 2013 Jan; 139(1):139-45. PubMed ID: 22986812
[TBL] [Abstract][Full Text] [Related]
3. Effect of nutritional status before radiotherapy on radiation-induced acute toxicities in patients with nasopharyngeal carcinoma.
Song X; Su L; Lin Q; Liu S; Zhang W; Hong J
Head Neck; 2023 Mar; 45(3):620-628. PubMed ID: 36600471
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K
Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297
[TBL] [Abstract][Full Text] [Related]
5. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.
Liang G; Du W; Ke Q; Huang B; Yang J
Adv Clin Exp Med; 2017; 26(3):409-413. PubMed ID: 28791814
[TBL] [Abstract][Full Text] [Related]
6. Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study.
Miao J; Wang L; Ong EHW; Hu C; Lin S; Chen X; Chen Y; Zhong Y; Jin F; Lin Q; Lin S; Hu X; Zhang N; Wang R; Wang C; Guo X; Yit NLF; Shi H; Tan SH; Mai H; Xie C; Chua MLK; Zhao C
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):815-825. PubMed ID: 36872457
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Han L; Lin SJ; Pan JJ; Chen CB; Zhang Y; Zhang XC; Liao XY; Chen QS
Chin J Cancer; 2010 Feb; 29(2):145-50. PubMed ID: 20109341
[TBL] [Abstract][Full Text] [Related]
8. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
Ren G; Du L; Ma L; Feng LC; Zhou GX; Qu BL; Xu SP; Xie CB; Ou GM; Li F; Zhang XX; Yang J
Technol Cancer Res Treat; 2011 Jun; 10(3):259-66. PubMed ID: 21517132
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.
Tao CJ; Liu X; Tang LL; Mao YP; Chen L; Li WF; Yu XL; Liu LZ; Zhang R; Lin AH; Ma J; Sun Y
Chin J Cancer; 2013 Oct; 32(10):525-32. PubMed ID: 24016394
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: Penang General Hospital experience.
Phua CE; Tan BS; Tan AL; Eng KY; Ng BS; Malik RA; Wan Ishak WZ
Asian Pac J Cancer Prev; 2012; 13(7):3287-92. PubMed ID: 22994749
[TBL] [Abstract][Full Text] [Related]
11. Symptom profile of nasopharyngeal cancer patients during radiation therapy.
Huang HY; Wilkie DJ; Schubert MM; Ting LL
Cancer Pract; 2000; 8(6):274-81. PubMed ID: 11898144
[TBL] [Abstract][Full Text] [Related]
12. Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.
Guo SP; Wu SG; Zhou J; Feng HX; Li FY; Wu YJ; Sun JY; He ZY
Drug Des Devel Ther; 2014; 8():497-503. PubMed ID: 24872680
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal carcinoma: current management, future directions and dental implications.
Agulnik M; Epstein JB
Oral Oncol; 2008 Jul; 44(7):617-27. PubMed ID: 18061518
[TBL] [Abstract][Full Text] [Related]
14. Oral care experiences with 181 nasopharyngeal carcinoma patients receiving radiotherapy in a Taiwanese hospital.
Wang WC; Chen YK; Lin LM
Auris Nasus Larynx; 2008 Jun; 35(2):230-4. PubMed ID: 17976937
[TBL] [Abstract][Full Text] [Related]
15. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
16. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
[TBL] [Abstract][Full Text] [Related]
17. The role of Indonesian patients' health behaviors in delaying the diagnosis of nasopharyngeal carcinoma.
Fles R; Bos ACRK; Supriyati ; Rachmawati D; Waliyanti E; Tan IB; Haryana SM; Schmidt MK; Dewi FST
BMC Public Health; 2017 May; 17(1):510. PubMed ID: 28545416
[TBL] [Abstract][Full Text] [Related]
18. Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy.
Xu Y; Teng F; Huang S; Lin Z; Yuan X; Zeng X; Yang F
Arch Oral Biol; 2014 Feb; 59(2):176-86. PubMed ID: 24370189
[TBL] [Abstract][Full Text] [Related]
19. Trismus, xerostomia and nutrition status in nasopharyngeal carcinoma survivors treated with radiation.
Chen YJ; Chen SC; Wang CP; Fang YY; Lee YH; Lou PJ; Ko JY; Chiang CC; Lai YH
Eur J Cancer Care (Engl); 2016 May; 25(3):440-8. PubMed ID: 25495287
[TBL] [Abstract][Full Text] [Related]
20. [Phase II clinical trial of two different modes of administration of the induction chemotherapy for locally advanced nasopharyngeal carcinoma].
Bi T; Jin F; Wu W; Long J; Li Y; Gong X; Luo X; Li Z; He Q; Qu B
Zhonghua Zhong Liu Za Zhi; 2015 Sep; 37(9):676-81. PubMed ID: 26813432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
